BACKGROUND More than 90% of patients developing heart failure (HF) have an
epidemiological background of hypertension. The most frequent concomitant conditions are …

More than 90% of patients developing heart failure (HF) have hypertension. The most
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …

Chronic heart failure (CHF) is associated with frequent hospitalizations and high mortality. It
affects more than 5 million individuals in the USA, and another 660,000 new cases are …

Introduction: Heart failure (HF) with preserved ejection fraction (EF)(HFpEF) accounts for
approximately 50% of HF cases and its prevalence relative to HF with reduced EF is rising …

In this update of the Canadian Cardiovascular Society heart failure (HF) guidelines, we
provide comprehensive recommendations and practical tips for the pharmacologic …

Importance Worldwide, the burden of heart failure has increased to an estimated 23 million
people, and approximately 50% of cases are HF with reduced ejection fraction (HFrEF) …

The treatment of heart failure (HF) with reduced ejection fraction (HFrEF) has substantially
developed over the past decades. More than ever before, the application of appropriate …

Abstract According to the 202 1 European Society of Cardiology guidelines, the four pillars
of medical therapy in heart failure with reduced ejection fraction (HFrEF) include sodium …

Heart failure (HF) is a major public health problem, and it is associated with increased
morbidity and mortality. As the US life expectancy increases and the population ages, the …

Hypertension is highly prevalent worldwide and is the major risk factor for heart failure (HF).
More than half of the patients with HF in Asia suffer from hypertension. According to the 2022 …